France· FR:67756414
DEXLIQ 4 mg/mL, solution buvable
A medicinal product containing phosphate sodique de dexaméthasone, registered in France by THERAVIA.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PHOSPHATE SODIQUE DE DEXAMÉTHASONE
- Manufacturer
- THERAVIA
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009301334461 flacon jaune (brun) de 30 ml avec fermeture de sécurité enfant avec adaptateur polyéthylène basse densité (PEBD) avec seringue(s) pour administration orale polyéthylène basse densité (PEBD)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Phosphate sodique de dexaméthasone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandDexliqTheravia
- United KingdomDecadron 4mg tabletsCST Pharma Ltd
- United StatesdexamethasonePreferred Pharmaceuticals Inc.
- CzechiaDEXAMETHASONE KRKAKrka, d.d., Novo mesto, Novo mesto
- PolandCovexanZakłady Farmaceutyczne POLPHARMA S.A.
- GermanyDexaHexal Ag
- SpainAMEXXINE 1 MG/ML COLIRIO EN SOLUCIONPharmaselect International Beteiligungs Gmbh
- Japanデキサメタゾン日医工
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Dexamethason Hcs, Dexamethason Kalceks
- Belgium · Darazon, Dexalis
- Bulgaria · Dexanova, Дeксаметазон Крка
- Cyprus · Axium-Opto, Decadron
- Czechia · Dexamed, Dexamethasone Fmk
- Germany · Dexa, Dexa Edo
- Denmark · Axiumopto, Dexacur
- Estonia · Caltrixan, Dexamethason Krka
- Spain · Amexxine, Dexafree
- Finland · Axiumopto, Dexacur
- United Kingdom (Northern Ireland) · Dexafree, Dexamethason Glenmark Pharmaceuticals Europe
- Greece · Amelinor, Axium
- Croatia · Darazur, Deksametazon Kalceks
- Hungary · Darazur, Dexamethasone Kalceks
- Ireland · Dexafree, Dexamethasone Activase Pharmaceuticals
- Iceland · Dexametason Abcur, Dexamethason Krka
- Italy · Amexzur, Cortmuper
- Liechtenstein · Neofordex, Ozurdex
- Lithuania · Dexamethason Krka, Dexamethasone Kalceks
- Luxembourg · Dexalis, Dexamethasone Kalceks
- Latvia · Dexamethason Krka, Dexamethasone Kalceks
- Malta · Axium-Opto, Decadron
- Netherlands · Axium-Opto, Dexamethason
- Norway · Dexacur, Dexametason Abcur
- Poland · Covexan, Darazur
- Portugal · Amexzur, Decadron
- Romania · Dexametazonă Fosfat Krka, Dexametazona Krka
- Sweden · Axiumopto, Baxil
- Slovenia · Deksametazon Krka, Deksametazon Medochemie
- Slovakia · Amexxine, Dexametazón Krka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cb373883-7bf6-4d3b-80b1-4fe82c30fe1b GET /v1/drugs/cb373883-7bf6-4d3b-80b1-4fe82c30fe1b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67756414",
"date_amm": "2018-01-19",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "PHOSPHATE SODIQUE DE DEXAMÉTHASONE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about phosphate sodique de dexaméthasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.